tiprankstipranks
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
US Market

Cannara Biotech (LOVFF) Income Statement

Compare
10 Followers

Cannara Biotech Income Statement

Last quarter (Q1 2025), Cannara Biotech's total revenue was C$25.07M, an increase of 28.68% from the same quarter last year. In Q1, Cannara Biotech's net income was C$2.31M. See Cannara Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
C$ 81.75MC$ 57.26MC$ 35.84MC$ 17.02MC$ 2.55M
Gross Profit
C$ 29.79MC$ 27.23MC$ 17.33MC$ 10.30MC$ 1.22M
Operating Expenses
C$ 19.71MC$ 15.34MC$ 12.36MC$ 10.00MC$ 13.15M
Depreciation and Amortization
C$ 6.35MC$ 4.94MC$ 3.92MC$ 3.03MC$ 2.58M
EBITDA
C$ 15.16MC$ 15.77MC$ 9.54MC$ 3.22MC$ -9.15M
Operating Income
C$ 10.08MC$ 11.89MC$ 3.67MC$ 192.60KC$ -11.93M
Other Income/Expenses
C$ -5.59MC$ -4.94MC$ -2.64MC$ -1.79MC$ -1.17M
Pretax Income
C$ 4.48MC$ 6.95MC$ 2.31MC$ -1.53MC$ -13.09M
Net Income
C$ 6.44MC$ 6.95MC$ 2.31MC$ -3.09MC$ -13.81M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ 0.07C$ 0.08C$ 0.03C$ -0.04C$ -0.19
Diluted EPS
C$ 0.07C$ 0.08C$ 0.03C$ -0.04C$ -0.19
Weighted Average Shares Outstanding
90.07M 89.30M 87.67M 76.52M 71.33M
Weighted Average Shares Outstanding (Diluted)
91.39M 89.30M 87.84M 76.52M 71.33M
Currency in CAD

Cannara Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis